Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Envista (NVST) stock in plain English

Free brief · no signupStart here
NVSTPublished Nov 15, 2026
Envista Holdings Corp
Healthcare · Medical Instruments & Supplies
Manufactures dental implants, orthodontic brackets, clear aligners, and diagnostic imaging equipment for dental professionals.
Assets:
Global production networkMaintains manufacturing plants in the United States, Switzerland, and Sweden
12,000 employeesStaffs sales, engineering, and manufacturing teams across worldwide facilities
Extensive consumables catalogSupplies restorative cements, impression trays, and endodontic instruments daily
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

82
OPS ScoreOperating finances
Latest quote
-2.02%$23.27
$3.73B
6.0×
$2.87B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 15, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was NVST. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Envista (NVST) do?

Envista Holdings Corp (NVST) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Manufactures dental implants, orthodontic brackets, clear aligners, and diagnostic imaging equipment for dental professionals. It manufactures dental implants, orthodontics, and restorative consumables across a coordinated worldwide supply chain. It is worth $3.73B on the market and sold $2.87B over the last year.

Market cap
$3.73B
P/E ratio
6.0×
Annual sales
$2.87B
Sector
Healthcare
Industry
Medical Instruments & Supplies
Brief updated
Nov 15, 2026

Brands and businesses behind NVST

  • Nobel Biocare: Manufactures dental implants and surgical prosthetics sold directly to oral surgeons.
  • Ormco: Produces orthodontic brackets, archwires, and Spark clear aligners for orthodontic clinics.
  • Kerr Dental: Sells restorative composites, impression materials, and rotary instruments to general dentists.
  • DEXIS: Supplies digital intraoral sensors, scanners, and 3D imaging equipment to dental offices.

NVST’s flags, in plain English

Each flag is a number from Envista’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 15, 2026.

Bargain or Trap?

Priced at 6 times its yearly profit, on the cheap side. The stock trades cheaper than it usually does. A low price can hide a real problem, so read the risks.

Fat Margins

Profit margin of 22%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.

Wide Gross Margin

Gross margin of 56.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Worth a Look

High debt obligations from past acquisitions require substantial cash for ongoing interest and principal payments. Something here could change the picture, so it is worth reading next to the good news.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about NVST

How big is Envista?

Envista’s market cap is $3.73B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $2.87B: what customers paid the company over the last year, before any costs.

What is NVST’s P/E ratio?

NVST’s P/E ratio is 6.0×. Investors pay about 6.0 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with NVST?

The first risk note on the card is Worth a Look, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Envista’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. NVST’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card